- Home
- OST vs APM Comparison
OST vs APM Comparison
Compare OST & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OST
- APM
- Stock Information
- Founded
- OST 2010
- APM 2010
- Country
- OST China
- APM United Kingdom
- Employees
- OST N/A
- APM N/A
- Industry
- OST Industrial Machinery/Components
- APM Biotechnology: Pharmaceutical Preparations
- Sector
- OST Technology
- APM Health Care
- Exchange
- OST Nasdaq
- APM Nasdaq
- Market Cap
- OST 15.7M
- APM 18.9M
- IPO Year
- OST 2022
- APM 2018
- Fundamental
- Price
- OST $1.66
- APM $1.85
- Analyst Decision
- OST
- APM
- Analyst Count
- OST 0
- APM 0
- Target Price
- OST N/A
- APM N/A
- AVG Volume (30 Days)
- OST 185.8K
- APM 20.3M
- Earning Date
- OST 09-19-2025
- APM 04-30-2025
- Dividend Yield
- OST N/A
- APM N/A
- EPS Growth
- OST N/A
- APM N/A
- EPS
- OST N/A
- APM N/A
- Revenue
- OST $38,333,251.00
- APM N/A
- Revenue This Year
- OST N/A
- APM N/A
- Revenue Next Year
- OST N/A
- APM N/A
- P/E Ratio
- OST N/A
- APM N/A
- Revenue Growth
- OST 0.34
- APM N/A
- 52 Week Low
- OST $1.35
- APM $0.46
- 52 Week High
- OST $235.00
- APM $7.49
- Technical
- Relative Strength Index (RSI)
- OST 26.79
- APM 50.26
- Support Level
- OST $1.50
- APM $1.64
- Resistance Level
- OST $2.07
- APM $1.90
- Average True Range (ATR)
- OST 0.23
- APM 0.36
- MACD
- OST 1.49
- APM -0.06
- Stochastic Oscillator
- OST 19.14
- APM 18.38
About OST Ostin Technology Group Co. Ltd.
Ostin Technology Group Co Ltd is a supplier of display modules and polarizers in China. It designs, develops, and manufactures TFT-LCD modules in a wide range of sizes and customized sizes according to the specifications of its customers. Its display modules are mainly used in consumer electronics, commercial LCD displays, and automotive displays. The company also manufactures polarizers used in the TFT-LCD display modules and is in the process of developing polarizers for the OLED display panel. Geographically, the company generates revenue from Hong Kong, Taiwan, and Mainland China which is its key revenue generating market.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.